Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.87 is 42% above its 4-year average of -1.49, near the high end of its 4-year range (-2.32–-0.53).
27.80% above its 12-month average of -1.21.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.18.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 4 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.87
EARNINGS PER SHARE (EPS) AVG TTM
-1.21
EARNINGS PER SHARE (EPS) AVG 3Y
-1.66
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+27.80%
CURRENT VS 3Y AVG
+47.51%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Filana Therapeutics, Inc.
Market Cap
$40.54M
Earnings Per Share (EPS)
-0.87
TTM Avg
-1.21
3Y Avg
-1.66
5Y Avg
N/A
Market Cap
$41.30M
Earnings Per Share (EPS)
-0.60
TTM Avg
-2.17
3Y Avg
-6.45
5Y Avg
-4.61
Market Cap
$39.06M
Earnings Per Share (EPS)
-2.49
TTM Avg
-2.22
3Y Avg
-1.86
5Y Avg
-2.21
Market Cap
$38.81M
Earnings Per Share (EPS)
-2.33
TTM Avg
-7.80
3Y Avg
-4.68
5Y Avg
-3.46
Market Cap
$42.15M
Earnings Per Share (EPS)
-0.65
TTM Avg
-1.58
3Y Avg
-4.60
5Y Avg
-6.89
Market Cap
$37.89M
Earnings Per Share (EPS)
0.16
TTM Avg
0.06
3Y Avg
-0.19
5Y Avg
-0.28
Market Cap
$37.94M
Earnings Per Share (EPS)
N/A
TTM Avg
-21.23
3Y Avg
-13.85
5Y Avg
-9.58
Market Cap
$43.31M
Earnings Per Share (EPS)
-1.68
TTM Avg
0.78
3Y Avg
0.08
5Y Avg
-0.02
Market Cap
$36.70M
Earnings Per Share (EPS)
-1.69
TTM Avg
-1.60
3Y Avg
-3.62
5Y Avg
-4.57
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Filana Therapeutics, Inc. (FLNA) | $40.54M | -0.87 | -1.21 | -1.66 | N/A |
| Veru Inc. (VERU)vs › | $41.30M | -0.60 | -2.17 | -6.45 | -4.61 |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.06M | -2.49 | -2.22 | -1.86 | -2.21 |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.81M | -2.33 | -7.80 | -4.68 | -3.46 |
| Precipio, Inc. (PRPO)vs › | $42.15M | -0.65 | -1.58 | -4.60 | -6.89 |
| Nephros, Inc. (NEPH)vs › | $37.89M | 0.16 | 0.06 | -0.19 | -0.28 |
| Incannex Healthcare Limited (IXHL)vs › | $37.94M | N/A | -21.23 | -13.85 | -9.58 |
| BioStem Technologies, Inc. (BSEM)vs › | $43.31M | -1.68 | 0.78 | 0.08 | -0.02 |
| Edesa Biotech, Inc. (EDSA)vs › | $36.70M | -1.69 | -1.60 | -3.62 | -4.57 |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.44M | -1.70 | -1.03 | -1.29 | -1.28 |
Trailing EPS (TTM)
$-0.87
Forward EPS (Est.)
$-0.89
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.88 |
| 2024-12-31 | -0.53 |
| 2023-12-31 | -2.32 |
| 2022-12-31 | -1.90 |
| 2021-12-31 | -0.82 |
